retatrutide fat loss clinical trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Biggest obesity news 🚨 TRIUMPH-1

GLP-1 RA, mainly liraglutide, might represent interesting molecules to tackle the weight excess that is associated with metabolic abnormalities, hyperandrogenism, infertility, and menstrual alterations in PCOS women

2/7) Starting with brain health

Buyers should request pharmacy name and Certificate of Analysis prior to dispensing

Understanding whether fatigue is a direct peptide effect or a caloric deficit symptom changes the management approach entirely

The GIP component appears to moderate the GI effects of the GLP-1 activation, which is the same reason Tirzepatide (dual GLP-1/GIP) is generally better tolerated than Semaglutide (GLP-1 only)

Note: Tirzepatide is technically a dual agonist (GLP-1 + GIP), meaning it targets two hormone receptors for potentially stronger effects